Viral Clearance Market Will Reach USD 900 Million By 2024, Globally: Zion Market Research

According to the report, the global viral clearance market was valued at approximately USD 230 million in 2017 and is expected to generate revenue of around USD 900 million by 2024, growing at a CAGR of around 21.41% between 2018 and 2024.

Sarasota, Florida, UNITED STATES


New York, NY, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Viral Clearance Market by Method (Viral Removal (Chromatography, Precipitation, and Nanofiltration) and Viral Inactivation (Low pH, Solvent Detergent Method, Pasteurization, and Other Viral Inactivation Methods)), by Application (Blood and Blood Products, Recombinant Proteins, Vaccines, and Other Applications), and by End-User (Pharmaceutical & Biotechnology Companies, Academic Research Institutes, CROs, and Other End-Users): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017–2024”. According to the report, the global viral clearance market was valued at approximately USD 230 million in 2017 and is expected to generate revenue of around USD 900 million by 2024, growing at a CAGR of around 21.41% between 2018 and 2024.

Biological products are prone to contamination with bacteria, fungi, and viruses. The source of contamination might be raw materials, improper culture handling, etc. Viral clearance is an important process during the downstream purification of therapeutic biologics, blood, and tissue-derived products. Viruses are either removed or inactivated. To produce microbiologically safe products, viral clearance plays a crucial role.

Browse through 82 Tables & 27 Figures spread over 110 Pages and in-depth TOC on “Global Viral Clearance Market: Industry Size, Share, Trends, Growth, Segments, Analysis and Forecast, 2017–2024”.

Request Free Sample Report of Global Viral Clearance Market Report @ https://www.zionmarketresearch.com/sample/viral-clearance-market

Recombinant proteins have high potency and lesser side effects. They mimic naturally occurring proteins and, hence, are widely used worldwide. Thus, the growth is observed in the biopharmaceutical research and development field. Advances and investments made in the biotechnology and pharmaceutical industries drive the viral clearance market. Additionally, favorable research funding and government grants for product development contribute notably toward this market’s growth. The need for virus clearance in cell culture to avoid contamination, high burden of chronic disorders, and an increasing aging population are also likely to contribute toward the viral clearance market. The high cost of technology and the time-consuming process of drug development might hamper this market’s growth. Growing demand for contract research organizations for pharmaceutical outsourcing along with potential emerging markets are likely to present lucrative opportunities for the viral clearance market in the upcoming years.

The viral clearance market is divided based on viral clearance method, application, and end-user. The viral clearance method segment is categorized into viral removal and viral inactivation. Viral removal segment is sub-segmented into chromatography, precipitation, and nanofiltration based on virus removal technique. The viral inactivation segment is sub-segmented into low pH, solvent detergent method, pasteurization, and other viral inactivation methods. In the viral removal segment, nanofiltration held the largest market share in 2017. Chromatographic viral removal segment is expected to grow at the fastest CAGR. By application, the viral clearance market is segmented into blood and blood products, recombinant proteins, vaccines, and other applications. The other applications include stem cell products, cellular and gene therapy products, tissue and tissue products etc. The recombinant proteins application segment dominated the market in 2017, owing to increased production and use of biosimilars and other therapeutic proteins for treating life-threatening diseases, such as cancer, diabetes, etc., globally. By end-user, this market includes pharmaceutical and biotechnology companies, academic research institutes, contract research organizations (CROs), and other end-users. The pharmaceutical and biotechnology companies segment dominated the viral clearance market in 2017 in terms of revenue share and is projected to lead during the forecast time period.

Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/viral-clearance-market

North America is a significant regional market for viral clearance. North America held almost 42% revenue share in 2017 and is a developed regional market for viral clearance. Increasing biopharmaceutical R&D activities and huge R&D investments made by biotechnology and pharmaceutical companies contribute toward the progress of the viral clearance market in this region. Additionally, rapidly growing life science research related to stem cell products, gene, and cellular therapy for cancer treatment, tissue-based therapies for heart, and liver, lung, and kidney disorders are likely to propel this regional market’s growth. Favorable research grant/fund and ongoing cell culture research activities in academic research institutes are other factors contributing toward the North American viral clearance market expansion. North America is projected to retain its leading position during the forecast time period. At the country level, the U.S was the dominant market in North America. Wide acceptance and use of viral clearance techniques in biopharmaceutical research, development, and manufacturing and the presence of dominant biopharmaceutical manufacturers and key players are anticipated to help strengthen this market in the U.S.

Europe is another major regional market for viral clearance. Stringent regulatory requirements for biopharmaceutical products and drug development research are driving this market in Europe. At the country level, Germany held the largest market share of the European viral clearance market in 2017 followed by the UK. Growing research related to stem cell research, tissue and tissue products development, and cellular therapy for cancer treatment are major factors driving this market’s growth in Germany and UK.

Browse the full "Viral Clearance Market by Method (Viral Removal (Chromatography, Precipitation, and Nanofiltration) and Viral Inactivation (Low pH, Solvent Detergent Method, Pasteurization, and Other Viral Inactivation Methods)), by Application (Blood and Blood Products, Recombinant Proteins, Vaccines, and Other Applications), and by End-User (Pharmaceutical & Biotechnology Companies, Academic Research Institutes, CROs, and Other End-Users): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017–2024" Report At https://www.zionmarketresearch.com/report/viral-clearance-market

The presence of a large number of contract research organizations for preclinical and clinical research services, favorable research funding, and government grants for drug development and research are driving the viral clearance market in the Asia Pacific region. During the forecast time period, the Asia Pacific region is projected to grow rapidly. Increased medical research funding in China, generic drug development in India, and a large geriatric population base prone to diseases in India, China, and Japan are contributing toward this regional market’s growth.

The Middle East and Africa is an underdeveloped viral clearance market and is likely to witness a slow rate of growth over the forecast time period, mainly due to the lack of research facilities and poor life science research activities in the region.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/viral-clearance-market

Some key players operating in the viral clearance market include Merck KGaA, Wuxi Biologics (Cayman), Charles River Laboratories International Inc., Kedrion, Texcell Inc., Vironova Biosafety, Clean Cells, BSL BIOSERVICE Scientific Laboratories Munich GmbH, and ViruSure GmbH, among others.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/3584

This report segments the global viral clearance market as follows:

Global Viral Clearance Market: By Method

  • Viral Removal 
    • Chromatography
    • Precipitation
    • Nanofiltration
  • Viral Inactivation
    • Low pH
    • Solvent Detergent Method
    • Pasteurization
    • Other Viral Inactivation Methods

Global Viral Clearance Market: By Application

  • Blood and Blood Products
  • Recombinant Proteins
  • Vaccines
  • Other Applications (Stem Cell Products, Cellular & Gene Therapy Products, Tissue & Tissue Products, etc.)

Global Viral Clearance Market: By End-User

  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations (CROs)
  • Other End-Users

Global Viral Clearance Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research

Blog: http://www.intenseresearch.com | http://www.mrsresearchgroup.com | http://www.marketresearchtrade.com | https://qyresearchgroup.com | http://marketnreports.com | https://zmrnewsjournal.us | http://www.e-marketresearch.com

Contact Us:

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Blog: http://zmrblog.com